Capricor Therapeutics (CAPR) Receivables - Other (2012 - 2024)
Capricor Therapeutics (CAPR) posted quarterly Receivables - Other of $10.0 million for Q4 2024, little changed year-over-year from $10.0 million in Q1 2024, and little changed quarter-over-quarter from $10.0 million in Q4 2023.
Capricor Therapeutics (CAPR) Receivables - Other (2012 - 2024) Analysis & Trends
Capricor Therapeutics' Receivables - Other history runs 10 years deep, the most recent figure standing at $10.0 million for Q4 2024.
- In Q4 2024, Receivables - Other changed 0.0% year-over-year to $10.0 million; the TTM figure through Dec 2024 stood at $10.0 million (changed 0.0% YoY), while the FY2024 annual figure was $10.0 million, changed 0.0% from the prior year.
- Receivables - Other for Q4 2024 stood at $10.0 million, roughly flat from $10.0 million in the prior quarter.
- The five-year high for Receivables - Other was $10.0 million in Q4 2023, with the low at $385.0 in Q2 2020.
- The 4-year median for Receivables - Other is $206000.0 (2021), against an average of $3.0 million.
- The sharpest annual moves came in 2020 and 2021: Receivables - Other dropped 3.45% in 2020, then soared 53406.49% in 2021.
- Capricor Therapeutics' Receivables - Other stood at $56000.0 in 2020, then surged by 267.86% to $206000.0 in 2021, then jumped by 4754.37% to $10.0 million in 2023, then changed by 0.0% to $10.0 million in 2024.
- Business Quant data shows CAPR's Receivables - Other at $10.0 million in Q4 2024, $10.0 million in Q4 2023, and $206000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Dec 31, 2023 | 10.00 Mn |
| Dec 31, 2023 | 10.00 Mn |
| Jun 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 206,000.00 |
| Mar 31, 2021 | 600,000.00 |
| Mar 31, 2021 | 600,000.00 |
| Dec 31, 2020 | 56,000.00 |
| Dec 31, 2020 | 56,000.00 |
| Jun 30, 2020 | 385.00 |
| Jun 30, 2020 | 385.00 |
| Mar 31, 2020 | 36,000.00 |
| Mar 31, 2020 | 36,000.00 |
| Dec 31, 2019 | 58,000.00 |
| Dec 31, 2019 | 58,000.00 |
| Mar 31, 2018 | 2.10 Mn |
| Mar 31, 2018 | 2.10 Mn |
| Dec 31, 2017 | 2.10 Mn |
| Dec 31, 2017 | 2.10 Mn |